Food Allergy Initiative

Finding a cure for life-threatening food allergies

Sign Up for our eNewsletter & Alerts
Print Page Print Page
Tell a Friend Tell a Friend

Intravenous QAX576 Treatment for Eosinophilic Esophagitis

Cincinnati Center for Eosinophilic Disorders
Cincinnati Children's Hospital Medical Center, OH

The Cincinnati Center for Eosinophilic Disorders at Cincinnati Children's Hospital Medical Center is currently conducting a double-blinded, randomized, placebo-controlled clinical trial of intravenous QAX576, a monoclonal antibody to interleukin-13 (IL-13), in the treatment of Eosinophilic Esophagitis (EE). The purpose of this study is to test the sfety and efficacy of intravenous QAX576 in patients aged 18-50 with EE.

See detailed information about this study.

 

Food Allergy Quick Reference

Peanut Milk Tree Nuts Soy Egg Seeds Shellfish Fish Wheat

Food Allergy Initiative

© Copyright Food Allergy Initiative. All rights reserved.
Home  |  Login  |  Legal Notice  |  Privacy  |  Site Map  |  Contact Us
Web Design & Development by Global Cloud®